TRPV1 and Hypercholesterolemia: These studies strongly suggest that the pharmacological stimulation of TRPV1 represents a promising pathway to induce angiogenesis in the presence of cardiovascular risk factors (i.e., hypercholesterolaemia) or upon an ischemic insult.